New York Codes, Rules and Regulations
Title 9 - EXECUTIVE DEPARTMENT
Subtitle B - Division of Alcoholic Beverage Control
Chapter II - Rules of the Office of Cannabis Management
Part 113 - Medical Cannabis
Section 113.18 - Reporting Dispensed Medical Cannabis Products

Current through Register Vol. 46, No. 39, September 25, 2024

(a) A record of all medical cannabis products that have been dispensed shall be filed electronically to the prescription monitoring program registry established pursuant to section 3343-a of Article 33 of the Public Health Law, utilizing a transmission format acceptable to the Office, not later than twenty-four (24) hours after the cannabis was dispensed to the certified patient or designated caregiver.

(b) The information filed to the prescription monitoring program registry for each medical cannabis product dispensed shall include but not be limited to:

(1) a serial number that will be generated by the dispensing site for each medical cannabis product dispensed to the certified patient or designated caregiver;

(2) an identification number which shall be populated by a number provided by the Office, to identify the registered organization's dispensing site;

(3) the patient's name, date of birth and gender;

(4) the patient's address, including street, city, state, zip code;

(5) the patient's certification identification number;

(6) if applicable, designated caregiver's name and registry identification number;

(7) the date the medical cannabis product was dispensed by the dispensing site;

(8) the metric quantity for the medical cannabis product;

(9) the medical cannabis product identifier code number, which shall be populated by a number provided by the Office, to represent the medical cannabis product that was dispensed to the certified patient or designated caregiver, as applicable;

(10) the number of days supply dispensed;

(11) the certifying practitioner's Drug Enforcement Administration number;

(12) the date the written certification was issued by the certifying practitioner; and

(13) the payment method.

(c) When applicable, a registered organization shall file a zero report to the prescription monitoring program registry, in a format acceptable to the Office. For the purposes of this section, a zero report shall mean a report that no medical cannabis product was dispensed by a registered organization during the relevant period of time. A zero report shall be submitted no later than fourteen (14) days following the most recent previously reported dispensing of a medical cannabis product or the submission of a prior zero report.

Disclaimer: These regulations may not be the most recent version. New York may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.